ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

Gallo Group Finds Another Human Virus

November 7, 1986

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009